Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New DNA-dependent protein kinase inhibitors identified at Chengdu Baiyu Pharmaceutical

July 30, 2021

Dizal (Jiangsu) Pharmaceutical discovers Bruton tyrosine kinase inhibitors

July 30, 2021

New serine-protein kinase ATM inhibitors described by Medshine Discovery

July 29, 2021

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent PD-1/PD-L1 inhibitors

July 29, 2021

New RORgammaT agonists identified at Sunshine Lake Pharma

July 29, 2021

Chengdu Baiyu Pharmaceutical presents new tetrahydrocannabinol derivatives

July 29, 2021

Bristol Myers Squibb patents diacylglycerol kinase alpha/zeta inhibitors

July 28, 2021

Dual GCGR and GLP-1 agonists patented by Merck & Co.

July 28, 2021

Medshine Discovery discovers ketohexokinase inhibitors

July 28, 2021

Jiangsu Simcere Pharmaceutical R&D describes TGF-beta receptor type-1 inhibitors

July 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...